Blog

Asterias’s stem cell therapy shows promise in study – Reuters


Reuters

Asterias's stem cell therapy shows promise in study
Reuters
Asterias Biotherapeutics Inc said initial data from a small study showed that its lead stem cell therapy could improve mobility in patients paralyzed by a spinal cord injury. The company's shares were up 25 percent at $5.26 in mid-day trading on heavy

and more »

2015-08-31 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.